Literature DB >> 1547755

Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy.

O Devinsky1, S Emoto, D S Goldstein, R Stull, R J Porter, W H Theodore, N S Nadi.   

Abstract

We measured CSF and serum concentrations of monoamines and monoamine metabolites in normal control subjects and in patients with partial epilepsy between and less than 2 h after complex partial seizures (CPS) or secondarily generalized tonic-clonic seizures (SGTCs). After SGTCs, concentrations of norepinephrine in CSF were significantly higher (p less than 0.05) than interictal concentrations, concentrations after PSs, and concentrations in control subjects. Serum epinephrine levels also were significantly higher after SGTCs than interictal and control subjects' levels. CSF HVA levels were significantly higher after PSs than interictal or control subjects' levels. CSF concentrations of norepinephrine and its intraneuronal metabolite, dihydroxyphenylglycol, were highly correlated, both interictally and following SGTCs, whereas correlations between serum and CSF levels of these catechols generally were not statistically significant. The results indicate that seizures are associated with release of catecholamines in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547755     DOI: 10.1111/j.1528-1157.1992.tb02315.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.

Authors:  Michael Moussouttas; Edwin W Lai; Keith Dombrowski; Thanh T Huynh; John Khoury; Gilberto Carmona; Matthew DeCaro; Karel Pacak
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

2.  Effect of chronic administration of phenytoin on regional monoamine levels in rat brain.

Authors:  M H Meshkibaf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

3.  Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2013-10-08       Impact factor: 3.996

4.  Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

5.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Brain energy metabolism during experimental neonatal seizures.

Authors:  Claude G Wasterlain; Kerry W Thompson; Lucie Suchomelova; Jerome Niquet
Journal:  Neurochem Res       Date:  2010-12-07       Impact factor: 3.996

Review 7.  Analysis of Catecholamines and Pterins in Inborn Errors of Monoamine Neurotransmitter Metabolism-From Past to Future.

Authors:  Sabine Jung-Klawitter; Oya Kuseyri Hübschmann
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

8.  Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects.

Authors:  Maja Tarailo-Graovac; Gabriella A Horvath; Clara D van Karnebeek; Ingrid Blydt-Hansen; Allison M Matthews; Vladimir Avramovic; Magda Price; Britt Drogemoller; Casper Shyr; Jessica Lee; Jill Mwenifumbo; Aisha Ghani; Sylvia Stockler; Jan M Friedman; Anna Lehman; Colin J Ross; Wyeth W Wasserman
Journal:  Neurogenetics       Date:  2021-07-02       Impact factor: 2.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.